These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12714609)

  • 41. Lacrimal Fossa Bony Changes in Chronic Primary Acquired Nasolacrimal Duct Obstruction and Acute Dacryocystitis.
    Ali MJ; Mishra DK; Bothra N
    Curr Eye Res; 2021 Aug; 46(8):1132-1136. PubMed ID: 33583297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surfactant proteins: Role in lacrimal drainage disorders.
    Ali MJ; Paulsen F
    Med Hypotheses; 2019 Mar; 124():35-36. PubMed ID: 30798912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa.
    Martínez-Antón A; Debolós C; Garrido M; Roca-Ferrer J; Barranco C; Alobid I; Xaubet A; Picado C; Mullol J
    Clin Exp Allergy; 2006 Apr; 36(4):448-57. PubMed ID: 16630149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantification of MUC2 and MUC5AC transcripts in human conjunctiva.
    McKenzie RW; Jumblatt JE; Jumblatt MM
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):703-8. PubMed ID: 10711684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anatomy and physiology of efferent tear ducts].
    Paulsen F
    Ophthalmologe; 2008 Apr; 105(4):339-45. PubMed ID: 18350298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The efferent lacrimal ducts of the human. Morphological and biochemical studies].
    Thale A; Paulsen F; Kohla G; Schauer R; Rochels R; Tillmann B
    Ophthalmologe; 2001 Jan; 98(1):67-73. PubMed ID: 11220274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland.
    Arango ME; Li P; Komatsu M; Montes C; Carraway CA; Carraway KL
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2749-56. PubMed ID: 11687512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective controlled study of vapor pressure tear osmolality and tear meniscus height in nasolacrimal duct obstruction.
    Stahl U; Francis IC; Stapleton F
    Am J Ophthalmol; 2006 Jun; 141(6):1051-6. PubMed ID: 16765672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lacrimal gland activity in lacrimal drainage obstruction: exploring the potential cross-talk between the tear secretion and outflow.
    Singh S; Srivastav S; Bothra N; Paulsen F; Ali MJ
    Br J Ophthalmol; 2024 Mar; 108(4):621-624. PubMed ID: 37142331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
    Yuksel N; Mutlu M; Kilicarslan A; Akcay E
    Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection of human efferent tear ducts by antimicrobial peptides.
    Paulsen FP; Pufe T; Schaudig U; Held-Feindt J; Lehmann J; Thale AB; Tillmann BN
    Adv Exp Med Biol; 2002; 506(Pt A):547-53. PubMed ID: 12613959
    [No Abstract]   [Full Text] [Related]  

  • 52. Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca.
    Song XJ; Li DQ; Farley W; Luo LH; Heuckeroth RO; Milbrandt J; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4223-9. PubMed ID: 14507865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cavernous body of the human efferent tear ducts: function in tear outflow mechanism.
    Paulsen FP; Thale AB; Hallmann UJ; Schaudig U; Tillmann BN
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):965-70. PubMed ID: 10752929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis.
    Kunert KS; Keane-Myers AM; Spurr-Michaud S; Tisdale AS; Gipson IK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2483-9. PubMed ID: 11581187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucins and contact lens wear.
    Hori Y; Argüeso P; Spurr-Michaud S; Gipson IK
    Cornea; 2006 Feb; 25(2):176-81. PubMed ID: 16371777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.
    Tıskaoğlu NS; Yazıcı A
    Orbit; 2023 Aug; 42(4):404-410. PubMed ID: 36069079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Micro-Reflux Test: a new test to evaluate nasolacrimal duct obstruction.
    Camara JG; Santiago MD; Rodriguez RE; Medalle RA; Young DA; Atebara NH
    Ophthalmology; 1999 Dec; 106(12):2319-21. PubMed ID: 10599664
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aquaporin expression in the lacrimal sac of patients with primary and functional nasolacrimal duct obstruction.
    Park J; Kim J; Kim M; Baek S
    Br J Ophthalmol; 2017 Apr; 101(4):519-524. PubMed ID: 27439740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Trefoil factor family gene and peptide expression in pterygium].
    Lafontaine PO; Arnal M; Buron N; Solary E; Lizard S; Bron A; Bara J; Gespach C; Creuzot-Garcher C
    J Fr Ophtalmol; 2003 Dec; 26(10):1007-14. PubMed ID: 14691392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Magnetic resonance imaging features of tear outflow and structural changes of the lacrimal sac and nasolacrimal duct in normal subjects with eyes closed].
    Si JR; Zhang YL
    Zhonghua Yan Ke Za Zhi; 2018 Mar; 54(3):205-211. PubMed ID: 29518880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.